Skip to main content

News

Explore the latest stories and publications from NCATS and our partners, see upcoming events, or explore the variety of resources we provide to better understand translational science and our work.

News

Read the latest news from NCATS and its collaborators whose research is supported through the Center’s programs, or follow coverage of NCATS' translational research activities through national and local media.

Forgoing One Food Treats Eosinophilic Esophagitis as Well as Excluding Six

February 27, 2023 - NCATS News

  • Rare Diseases Clinical Research Network (RDCRN)

NIH grantees report results of first multi-site randomized trial comparing the two diets.

Analysis Reveals Nationwide Spread of Three Historically Regional and Potentially Life-Threatening Fungal Infections

February 17, 2023 - NCATS News

  • Clinical and Translational Science Awards (CTSA) Program

CTSA Program–supported research found that three fungal infections spread outside their usual regions and now appear in at least half of the United States. These findings could speed recognition and treatment outside typical areas of infection.

NIH RECOVER Research Identifies Potential Long COVID Disparities

February 16, 2023 - NCATS News

  • Clinical and Translational Science Awards (CTSA) Program

NIH-supported studies show variations in symptoms and diagnostic experiences among different racial and ethnic groups.

Lessons Learned From the NIH-Led Research Response to COVID-19

February 2, 2023 - NCATS News

  • COVID-19

Experience will inform the public health research response to future pandemics.

New 3-D Model Offers Insights into the Role of Glucose in a Deadly Kidney Disease

January 5, 2023 - NCATS News

  • Tissue Chip for Drug Screening

NIH-supported researchers combined organ-in-a-dish and organ-on-a-chip technologies to better understand polycystic kidney disease (PKD) and show the role of glucose in forming PKD cysts. This approach could lead to ways to test drugs and develop treatments.

Efficient Registry Approach Powers Practice-Shaping Infant Heart Surgery Trial

December 2, 2022 - NCATS News

  • Clinical and Translational Science Awards (CTSA) Program

A clinical trial of 1,200 infants undergoing congenital heart disease surgery found that an anti-inflammatory steroid did not perform better than a placebo at reducing risk of severe outcomes, except for some subgroups of infants.

Last updated on July 9, 2026